Truist Financial Begins Coverage on Tandem Diabetes Care (NASDAQ:TNDM)
Truist Financial assumed coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) in a research note issued to investors on Monday morning, MarketBeat reports. The brokerage issued a hold rating and a $24.00 target price on the medical device company’s stock. A number of other analysts have also weighed in on the company. […]
Truist Financial assumed coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) in a research note issued to investors on Monday morning, MarketBeat reports. The brokerage issued a hold rating and a $24.00 target price on the medical device company’s stock. A number of other analysts have also weighed in on the company. […]
